LCENA BATEMAN: Open Payments
NPI 1245003557 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 50 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $452 |
| Axsome Therapeutics, Inc. | 3 | $159 |
| SK Life Science, Inc. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| ARGENX US, INC. | 1 | $33 |
| UCB, Inc. | 1 | $32 |
| Amgen Inc. | 1 | $25 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
Products named: QULIPTA, UBRELVY, Symbravo, KESIMPTA, VYVGART HYTRULO, Rystiggo, UPLIZNA, DAYBUE.
Industry payments across TX — which companies pay providers there.
